Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review

Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review

ObjectiveThis study aims to delineate the clinical features underlying the concurrent disease of neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG), and to identify efficacious therapeutic strategies.BackgroundNMOSD and MG are uncommon autoimmune diseases that infrequently co-...

Full description

Bibliographic Details
Main Authors: Xiaoqian Song, Jingjiao Chen, Chenyang Jin, Yilong Peng, Yuewen Sun, Xueping Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
neuromyelitis optica spectrum disorder
myasthenia gravis
inebilizumab
anti-AQP4 antibodies
anti-acetylcholine receptors antibodies
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528989/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528989/full

Similar Items